Bausch + Lomb’s Zenlens® CHROMA HOA™ represents a major advancement in scleral lens technology, delivering precision vision correction through a fully customized, wavefront-guided design. This lens specifically targets higher-order aberrations (HOAs), which are complex visual distortions not corrected by traditional lenses or glasses. By utilizing technologies such as SmartCurve™ and Bi-Elevation™, the lens ensures optimal fit and stability, providing a secure platform for accurate HOA correction. Collaboration with OVITZ® and its xwave aberrometer enables precise mapping of each patient’s eye, allowing for highly personalized lens manufacturing through Advance Medical’s FocalPoints® platform.

The Zenlens CHROMA HOA™ meets a long-standing clinical need for patients suffering from vision impairment due to irregular corneas, keratoconus, or other corneal anomalies. Traditional vision correction methods often fall short for these individuals, leaving them with persistent symptoms like halos, glare, and poor night vision. This innovative lens offers a new level of clarity, improving not only functional vision but also the overall quality of life. By providing a tailored solution to a complex problem, Zenlens CHROMA HOA™ enhances the clinical toolkit available to eye care professionals.

The U.S. launch of Zenlens CHROMA HOA™ marks a significant step forward in specialty contact lens care, reaffirming Bausch + Lomb’s leadership in vision health innovation. By combining cutting-edge technology, personalized design, and robust professional support, the company is expanding access to advanced visual correction for a broader patient population. This breakthrough highlights the future of optometry—where high customization and precision optics redefine what patients can expect from their contact lenses.